For lyophilized powder, accidental freezing is not a concern, it is actually how you want to store long-term supply
Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre, randomized, double-blind, placebo-controlled phase 3a clinical trial
To view or add a comment, sign in Why does one GLP-1 drug require a daily injection while another lasts a full week
In a study comparing the effects of semaglutide and tirzepatide for weight loss, those receiving tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss and experienced larger reductions in body weight at 3, 6, and 12 months
Results may vary from person to person depending on factors such as lifestyle, diet, and individual body response
Clinical research shows semaglutide produces average weight loss of approximately 15% at 12 months, while tirzepatide demonstrates even more dramatic results with up to 20% average weight loss in the same timeframe